EP Patent

EP2563117A4 — FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALE SUBJECTS

Assigned to Salix Pharmaceuticals Ltd · Expires 2013-09-04 · 13y expired

What this patent protects

Patent listed against balsalazide-disodium.

Drugs covered by this patent

balsalazide-disodium (BALSALAZIDE DISODIUM)

Patent Metadata

Patent number: EP2563117A4
Jurisdiction: EP
Classification: —
Expires: 2013-09-04
Drug substance claim: No
Drug product claim: No
Assignee: Salix Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.